LPL Financial
EW icon

LPL Financial’s Edwards Lifesciences EW Stock Holding History

LPL Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$256K – 6041
2025
Q4 		$256K Hold
3,000
– – ﹤0.01% 5272
2025
Q3 		$233K Sell
3,000
-2,000
-40% -$156K ﹤0.01% 5237
2025
Q2 		$391K Buy
+5,000
New +$373K ﹤0.01% 4575

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

LPL Financial's EW Position: Q2 2026 in Review

LPL Financial increased its Edwards Lifesciences (EW) stake by 9.4% in Q2 2026, buying an estimated $2.78M and bringing the position to 386,755 shares worth $35M. The position accounts for 0.01% of the portfolio, ranked #1212.

LPL Financial first reported a position in EW in Q3 2013 and has held it in 52 quarters since. The position peaked at $37M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • LPL Financial held 386,755 shares of Edwards Lifesciences worth $35M as of Q2 2026.
  • LPL Financial bought 33,164 Edwards Lifesciences shares in Q2 2026, an estimated $2.78M.
  • Edwards Lifesciences made up 0.01% of LPL Financial's portfolio in Q2 2026, its #1212 holding.
  • LPL Financial first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 52 quarters since.
  • LPL Financial's Edwards Lifesciences position peaked at $37M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.